The-Open-Group OG0-093 Free Practice Questions

Q1. Which section of the TOGAF template for Architecture Principles should clearly state the impact to the business and consequences of adopting the principle? 

A. Implications 

B. Name 

C. Rationale 

D. Statement 

View Answer

Q2. Which of the following describes en objective of the Preliminary Phase? 

A. Develop a vision of the proposed enterprise architecture 

B. Document the baseline architecture 

C. Obtain approval for the Statement of Architecture Work 

D. Operate the governance framework 

E. Select and implement tools 

View Answer

Q3. What level of the Architecture Landscape provides a long-term summary view of the entire enterprise? 

A. Capability Architecture 

B. Operational Architecture 

C. Segment Architecture 

D. Strategic Architecture 

E. Tactical Architecture 

View Answer

Q4. Scenario: MedInc Products Ltd. 

Please read this scenario prior to answering the Question. 

MedInc Products Ltd. is a leading medical device manufacturer in the highly competitive market for Migraine Headache Pain Management (MHPM) devices. These tiny wireless devices are implanted in the brain and can deliver a precise electric shock when the wearable Pain Control Unit (PCU) detects an increase in stress induced by the onset of a migraine headache. This technology will be a breakthrough in the treatment of this condition, and several competitors are striving to be the first to introduce a product into the market. However, all of them must demonstrate the effectiveness and safety of their products in a set of clinical trials that will satisfy the regulatory requirements of the countries in the target markets. 

The Enterprise Architecture group at MedInc Products has been engaged in an architecture development project to create a secure networked collaboration system that will allow researchers at its product development laboratories worldwide to share information about their independent clinical trials. The Enterprise Architecture group is a mature organization that has been utilizing TOGAF for several years. The MedInc Architecture Development Method is strictly based on TOGAF 9 with extensions required to support current good manufacturing practices and good laboratory practices in their target markets. The project team has now completed the Business, Information Systems, and Technology Architecture phases and has produced a complete set of deliverables for each phase. Due to the highly sensitive nature of the information that is managed, special care was taken to ensure that each architecture domain included an examination of the security and privacy issues that are relevant for each domain. A corresponding Security Architecture has been defined. 

The Executive Vice President for Clinical Research is the sponsor of the Enterprise Architecture activity. He has stated that the changes to the enterprise architecture for the new system will need to be rolled out on a geographic basis that will minimize disruptions to ongoing clinical trials. The work will need to be done in stages and rolled out in geographical regions. 

Refer to the Medlnc Products Ltd. Scenario 

You are serving as the Lead Architect for the project team. 

You have been asked to recommend the approach to identify the work packages that will be included in the Transition Architecture(s). 

Based on TOGAF 9, which of the following is the best answer? 

A. Create an Implementation Factor Assessment and Deduction Matrix and a Consolidated Gaps, Solutions and Dependencies Matrix. For each gap, identify a proposed solution and classify it as new development, purchased solution, or based on an existing product. Group similar solutions together to form work packages. Identify dependencies between work packages factoring in the clinical trial schedules. Regroup the packages into a set of Capability Increments scheduled into a series of Transition Architectures and documented in an Architecture Definition Increments Table. 

B. Determine the set of Solution Building Blocks required by identifying which Solution Building Blocks need to be developed and which need to be procured. Eliminate any duplicate building blocks. Group the remaining Solution Building Blocks together to create the work packages using a CRUD matrix. Rank the work packages in terms of cost and select the most cost-effective options for inclusion in a series of Transition Architectures. Schedule the roll out of the work packages to be sequential across the geographic regions. 

C. Use a Consolidated Gaps, Solutions and Dependencies Matrix as a planning tool. For each gap classify whether the solution is either a new development, purchased solution, or based on an existing product. Group the similar solutions together to define the work packages. Regroup the work packages into a set of Capability Increments to transition to the Target Architecture taking into account the schedule for clinical trials. 

D. Group the Solution Building Blocks from a Consolidated Gaps, Solutions and Dependencies Matrix into a set of work packages. Using the matrix as a planning tool, regroup the work packages to account for dependencies. Sequence the work packages into the Capability Increments needed to achieve the Target Architecture. Schedule the rollout one region at a time. Document the progression of the enterprise architecture using an Enterprise Architecture State Evolution table. 

View Answer

Q5. Which ADM phase starts with the receipt of a Request for Architecture Work from the sponsoring organization? 

A. Phase A 

B. Phase B 

C. Phase H 

D. Preliminary Phase 

E. Requirements Management 

View Answer

Q6. According to TOGAF, which of the following best describes the purpose of a Compliance Assessment? 

A. To ensure that architecture information is communicated to the right stakeholders at the right time 

B. To govern the architecture throughout its implementation process 

C. To provide a high-level view of the end architecture product 

D. To show progression of change from the Baseline Architecture to the Target Architecture 

View Answer

Q7. The TOGAF ADM uses a version numbering convention to illustrate the evolution of Baseline and Target Architecture Definitions. What does Version 1.0 indicate according to this convention? 

A. A high-level outline architecture 

B. A preliminary outline architecture 

C. A formally reviewed, detailed architecture 

D. A draft, detailed architecture 

E. A formally reviewed, preliminary architecture 

View Answer

Q8. Which of the following best describes how TOGAF defines an enterprise? 

A. Any collection of organizations that has a common set of goals 

B. Any corporation with more than 10,000 employees 

C. Any organization involved in commerce 

D. Any organization whose stock is traded 

E. Any set of organizations based at the same geographic location 

View Answer

Q9. Which of the following does the TOGAF document define as the representation of a related set of concerns? 

A. Catalog 

B. Matrix 

C. Diagram 

D. View 

E. Viewpoint 

View Answer

Q10. According to TOGAF, how is the Enterprise Continuum used in organizing and developing an architecture? 

A. To aid communication and understanding between architects 

B. To coordinate with the other management frameworks in use 

C. To describe how an architecture addresses stakeholder concerns 

D. To evaluate how best to develop and implement an architecture 

E. To help identify and understand business requirements 

View Answer

Q11. Scenario 

Please read this scenario prior to answering the Question 

You are serving as the Lead Architect for an enterprise architecture project team within a leading multinational pharmaceutical and medical devices manufacturer. Its brands include numerous household names for medications and first aid supplies. 

The company has a long history of innovating new treatments for many common illnesses and diseases. Prior to launching a new treatment, the company has to demonstrate Its effectiveness and safety in a set of clinical trials that satisfy the regulatory requirements of the countries in the target markets. All clinical trials are undertaken by its research laboratories, which employ over 10,000 people at separate facilities in the United Kingdom, United States, Sweden, France, Canada, India, China and Japan. In addition to internal research and development activities the company is also involved in publicly funded collaborative research projects, with other industrial and academic partners. 

The Enterprise Architecture group within the company has been engaged in an architecture development project to create a secure networked collaboration system that will allow researchers at its product development laboratories worldwide to share information about their clinical trials. This system will also connect with external partners. 

The Enterprise Architecture group within the company has been engaged in an architecture development project to create a secure networked collaboration system that will allow researchers at its product development laboratories worldwide to share information about their clinical trials. This system will also connect with external partners. 

The Enterprise Architecture group is a mature organization. They use the TOGAF 9 ADM with extensions required to support current good manufacturing practices and good laboratory practices in their target markets. Due to the highly sensitive nature of the information that is managed, special care was taken to ensure that each architecture domain included an examination of the security and privacy issues that are relevant. 

The Executive Vice President for Clinical Research is the sponsor of the Enterprise Architecture activity. She has stated that the changes to the enterprise architecture for the new system will need to be rolled out in stages on a regional basis that minimizes disruptions to ongoing clinical trials. 

Refer to the Scenario 

You have been asked to recommend the approach to identify the work packages that will be included in the Transition Architecture(s). 

Based on TOGAF, which of the following is the best answer? 

A. Determine the set of Solution Building Blocks required by identifying which Solution Building Blocks need to be developed and which need to be procured. Eliminate any duplicate building blocks. Group the remaining Solution Building Blocks together to create the work packages using a CRUD matrix. Rank the work packages in terms of cost and select the most cost-effective options for inclusion in a series of Transition Architectures. Schedule the roll out of the work packages to be sequential across the geographic regions. 

B. Create an Implementation Factor Assessment and Deduction Matrix and a Consolidated Gaps, Solutions and Dependencies Matrix. For each gap, identify a proposed solution and classify it as new development, purchased solution, or based on an existing product. Group similar solutions together to form work packages. Identify dependencies between work packages factoring in the clinical trial schedules. Regroup the packages into a set of Capability Increments scheduled into a series of Transition Architectures. 

C. Group the Solution Building Blocks from a Consolidated Gaps, Solutions and Dependencies Matrix into a set of work packages. Using the matrix as a planning tool, regroup the work packages to account for dependencies. Sequence the work packages into the Capability Increments needed to achieve the Target Architecture. Schedule the rollout one region at a time. Document the progression of the enterprise architecture using a state evolution table. 

D. Use a Consolidated Gaps, Solutions and Dependencies Matrix as a planning tool. For each gap classify whether the solution is either a new development, purchased solution, or based on an existing product. Group the similar solutions together to define the work packages. Regroup the work packages into a set of Capability Increments to transition to the Target Architecture taking into account the schedule for clinical trials. 

View Answer

Q12. Which of the following is defined by TOGAF as a representation of a system from the perspective of a related set of concerns? 

A. Architecture Building Block 

B. Capability Architecture 

C. Statement of Work 

D. View 

E. Viewpoint 

View Answer

Q13. Scenario: 

Please read this scenario prior to answering the Question 

You are the Lead Architect for a firm that manufactures ball bearings used in industrial equipment applications. They have manufacturing operations in several cities in the United States, Germany, and the United Kingdom. 

The firm has traditionally allowed each manufacturing plant to drive its own production planning systems. Each plant has its own custom Materials Requirements Planning, Master Production Scheduling, Bill of Materials, and Shop Floor Control systems. 

"Just In Time" manufacturing techniques are used to minimize wastes caused by excessive inventory and work in process. The increasingly competitive business environment has compelled the firm to improve its business capability to be more responsive to the needs of industrial customers. To support this capability, the firm has decided to implement an Enterprise Resource Planning (ERP) solution that will enable it to better coordinate its manufacturing capacity to match the demands for its products across all plants. In addition, there are also new European regulations coming into force to which their manufacturing processes must conform in the next six months. 

As part of the implementation process, the Enterprise Architecture (EA) department has begun to implement an architecture process based on TOGAF 9. The CIO is the sponsor of the activity. The Chief Architect has directed that the program should include formal modeling using the Architecture Content Framework and the TOGAF Content Metamodel. This will enable support for the architecture tooling that the firm uses for its EA program. 

The Chief Architect has stated that in order to model the complex manufacturing process it will be necessary to model processes that are event-driven. Also, in order to consolidate applications across several data centers it will be necessary to model the location of IT assets. In particular, the end goal is to have the single ERP application running in a single data center. 

Currently the project is in the Preliminary Phase, and the architects are tailoring the Architecture Development Method (ADM) and Architecture Content Framework to fit into the corporate environment. 

Refer to the Scenario 

You have been asked to recommend a response to the Chief Architect's request to tailor the TOGAF Content Metamodel. 

Based on TOGAF 9, which of the following is the best answer? 

A. You recommend that the architecture team incorporate the Process Modeling and Infrastructure Consolidation extensions into their tailored Content Metamodel. As the environment is process-centric this will enable them to model the manufacturing processes and store information to support regulatory compliance. It also includes views useful for managing the consolidation of applications into a single data center. 

B. You recommend that the architecture team incorporate the Process Modeling and Governance extensions into their tailored Content Metamodel. This is suitable as this is a significant IT change that will impact its operational models. This will ensure that they include specific entities and attributes that will allow them to model the event-driven nature of the manufacturing processes more precisely. 

C. You recommend that the architecture team incorporates the Governance and Motivation Extensions into their tailored Content Metamodel. This would allow modeling of the target milestones they want to achieve with this consolidation of application to a single data center. These extensions will also enable demonstration of regulatory compliance for the manufacturing process. 

D. You recommend that the architecture team incorporates the Data and Services Extensions into their tailored Content Metamodel. This would allow modeling of the location of IT assets and ensure regulatory compliance for the manufacturing process. It will also allow for identification of redundant duplication of capability which will be needed for a successful consolidation to a single data center. 

View Answer

Q14. Which of the following is an objective of Phase B, Business Architecture? 

A. To confirm the ability of the enterprise to undergo change 

B. To demonstrate how stakeholder concerns are addressed in the Business Architecture 

C. To develop a Target Technology Architecture to support the business 

D. To finalize the Architecture Vision and Architecture Definition documents 

E. To maximize the business value from the architecture 

View Answer

Q15. Which one of the following is responsible for the acceptance and sign-off of an Architecture Compliance review? 

A. Architecture Board 

B. Architecture Review Co-ordinator 

C. CIO 

D. Lead Enterprise Architect 

E. Project Leader 

View Answer

Q16. In which of the following ADM Phases do building blocks become implementation-specific? 

A. Phase A 

B. Phase B 

C. Phase C 

D. Phase D 

E. Phase E 

View Answer